Storage of cord blood attracts private-sector interest

Hass, Janis
February 1999
CMAJ: Canadian Medical Association Journal;2/23/99, Vol. 160 Issue 4, p551
Academic Journal
Reports on the debate about the collection, storage and use of umbilical-cord blood, containing hematopoietic stem cells. Development of three private umbilical-cord banks in Canada; Advantages of stem cells over bone marrow; Possible stem cell use in gene therapy and treatment of cancers; Opinions of stem cell use; The issues of public versus private health care.


Related Articles

  • 826. Transduction of Human Hematopoietic Stem Cells by RD114-TR-Pseudotyped Lentiviral Vectors. Stornaiuolo, Anna A.; Di Nunzio, Francesca F.; Piovani, Bianca B.; Cosset, Francois F.-L.; Mavilio, Fulvio F. // Molecular Therapy;Jun2006, Vol. 13, pS320 

    HIV-1-derived lentiviral vectors are efficiently pseudotyped by a chimeric envelope (RD114-TR) encoding the extracellular and transmembrane domains of the FLV RD114 glycoprotein fused to cytoplasmic tail (TR) of the MLV 4070A amphotropic glycoprotein. RD114-TR pseudotyped vectors may be...

  • Knockdown of HPRT for Selection of Genetically Modified Human Hematopoietic Progenitor Cells. Choudhary, Rashmi; Baturin, Dmitry; Fosmire, Susan; Freed, Brian; Porter, Christopher C. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    The inability to obtain sufficient numbers of transduced cells remains a limitation in gene therapy. One strategy to address this limitation is in vivo pharmacologic selection of transduced cells. We have previously shown that knockdown of HPRT using lentiviral delivered shRNA facilitates...

  • Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Staal, F. J. T.; Cowan, C.; Dzierzak, E.; Hacein-Bey-Abina, S.; Karlsson, S.; Lapidot, T.; Lemischka, I.; Mendez-Ferrer, S.; Mikkers, H.; Moore, K.; Moreno, E.; Mummery, E. L.; Robin, C.; Suda, T.; Van Pel, M.; Vanden Brink, G.; Zwaginga, J. J.; Fibbe, W. E. // Leukemia (08876924);Jul2011, Vol. 25 Issue 7, p1095 

    The hematopoietic stem cell (HSC) is the prototype organ-regenerating stem cell (SC), and by far the most studied type of SC in the body. Currently, HSC-based therapy is the only routinely used SC therapy; however, advances in the field of embryonic SCs and induced pluripotent SCs may change...

  • Current status of Cord Blood Banking During First Two Years of 'National Government-Assigned Public Cord Blood Banks Operation' in Korea. Roh, Eun; Lee, Jung; Yoon, Jong; Kim, Su; Lee, Kyung; Song, Do; Kim, Tai; Shin, Sue // Stem Cell Reviews & Reports;Oct2014, Vol. 10 Issue 5, p627 

    Cord blood (CB) has become a viable stem cell source for hematopoietic stem cell transplantation (HSCT), and public cord blood banks (CBBs) have been established to manage donated cord blood units (CBUs) for unrelated HSCT. As the potential uses for CB continue to grow, there is a global...

  • Educating patients about the value of umbilical cord blood donation. Skabla, Patsy Lynn; McGadney-Douglas, Brenda; Hampton, James // JAAPA: Journal of the American Academy of Physician Assistants (;Nov2010, Vol. 23 Issue 11, p33 

    The article focuses on the importance of educating patients on the significance of umbilical cord blood (UCB) donation in the U.S. It mentions that UCB has been a valuable resource for patients lacking appropriate stem donors and is readily available wherein the collection is less invasive. It...

  • Establishing a Public Umbilical Cord Blood Stem Cell Bank for South Africa: An Enquiry into Public Acceptability. Meissner-Roloff, Madelein; Pepper, Michael S. // Stem Cell Reviews & Reports;Dec2013, Vol. 9 Issue 6, p752 

    South Africa (SA) faces a large unmet need for bone marrow (BM) transplantation, which could be alleviated in part by establishing a public umbilical cord blood stem cell bank (UCB SCB). Umbilical cord blood is an increasingly utilised source of hematopoietic stem cells for BM transplantation in...

  • Cord Blood Stem Cell Network Proposed. Mitka, Mike // JAMA: Journal of the American Medical Association;5/18/2005, Vol. 293 Issue 19, p2332 

    Reports on the efforts of the Institute of Medicine (IOM) to establish a national cord blood stem cell bank in the U.S. Suggestion of the IOM that the U.S. Department of Health and Human Services establish a National Cord Blood Policy Board to regulate the therapeutic use of cord blood stem...

  • Betting on HSCs.  // Nature Immunology;Apr2002, Vol. 3 Issue 4, p307 

    Focuses on hematopoietic stem cells (HSCs) as the gene-delivery vehicle or source of corrective cells. State of HSC biology; Gene therapies; Ability to culture hematopoietic progenitors.

  • Corrigendum to 'Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects'.  // Molecular Therapy;Feb2012, Vol. 20 Issue 2, p469 

    A correction to the article "Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects" that was published in the 2012 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics